Nano-vehicles deliver drugs where they’re needed

EU-funded researchers have developed nano-vehicles that can overcome the body’s immune response and biological barriers to deliver drugs to the target site.

The drugs used to treat serious diseases such as cancer and Alzheimer’s aren’t nearly as effective as they could be. For Alzheimer’s, only 30 % of patients respond to therapy, a sobering statistic considering there are about 33 million people in the world with the disease. The response rate for cancer is even lower. A mere quarter reacts positively to treatment and 9.6 million people die each year from various forms of the disease.

During the EU-funded project NABBA, young researchers worked on innovative solutions that would improve drug efficacy in diseases with very poor response rates. The project team developed nano-vehicles to improve drug delivery, with promising results.

CONTINUE READING ON cordis.europa.eu